Skip to main content

Day: February 28, 2025

Change to Board of Directors

Bang & Olufsen A/S announces that M. Claire Chung will not seek re-election to the Board of Directors at the upcoming annual general meeting in August 2025 and will step down effective 28 February 2025. This decision reflects her wish to focus on personal priorities. Chair of the Board of Directors, Juha Christensen comments: “Claire Chung joined the Board of Director’s in 2019, and I’m truly grateful for her significant contributions as a member of the Board and in our Remuneration Committee.” Claire Chung has conveyed her appreciation for the chance to collaborate with the Board and Management team, expressing strong confidence in their leadership and the strategic direction.For further information, please contact: Cristina Rønde HeftingSr. Director, Head of Strategy & Investor Relations Phone: +45 4153 7303Attachment...

Continue reading

Framboð til stjórnar og varastjórnar Sláturfélags Suðurlands svf. á aðalfundi 21.mars 2025

Framboð til stjórnar og varastjórnar Sláturfélags Suðurlands svf. á aðalfundi 21. mars 2025. Framboð til stjórnar og varastjórnar skal hafa borist skriflega í hendur stjórnarinnar eigi síðar en þremur vikum fyrir aðalfund í samræmi við 2. mgr. 27. gr. samþykkta félagsins. Framboð hefur borist innan tilskilins frests frá eftirtöldum aðilum: Til setu í aðalstjórnGuðrún S. Magnúsdóttir, Bræðratungu, 806 SelfossiHallfreður Vilhjálmsson, Kambshóli, 301 AkranesiLilja Guðrún Eyþórsdóttir, Vestri-Reynir, 301 AkranesiSverrir Gíslason, Kirkjubæjarklaustur 2, 880 KirkjubæjarklaustriÞorsteinn Logi Einarsson, Egilsstaðir 2, 803 Selfossi Til setu í varastjórnÁslaug Finnsdóttir, Hömrum, 371 Búðardal        Eiríkur Jónsson, Gýgjarhólskoti 1, 806 SelfossiGuðmundur H. Davíðsson, Miðdal, 276 MosfellsbæGunnar Sigurjónsson, Litla-Hofi, 785 ÖræfumMagðalena...

Continue reading

Admiral Markets AS Unaudited Financial Results 12 Months of 2024

Admiral Markets AS Unaudited Financial Results 12 Months of 2024Despite lower client activity, Admirals Markets AS delivered resilient trading income and positive net profit through effective cost control measures. Net trading income increased by 48% to EUR 13.5 million (2023: EUR 9.1 million) being supported by higher volatility on the financial markets.Total operating expenses decreased by 26% to EUR 13.7 million (2023: EUR 18.5 million).EBITDA was EUR 2.0 million (2023: EUR -6.9 million).Net profit was EUR 1.3 million (2023: EUR -8.2 million).Although the income was supported by higher volatility in financial markets, Admirals Group’s cost optimisation effort was partly muted due to voluntary suspension of new client registrations in the Cyprus based operating company Admirals Europe Ltd. This...

Continue reading

Admirals Group AS Unaudited Financial Results for 12 months of 2024

Admirals Group AS Unaudited Financial Results for 12 months of 2024 Despite lower client activity, Admirals Group AS delivered resilient trading income and positive EBITDA through effective cost control measures. • The Group’s net trading income decreased by 6% to EUR 38.4 million (2023: EUR 40.9 million), being supported by higher volatility on the financial markets. • The Group’s total operating expenses decreased by 16% to EUR 42.4 million (2023: EUR 50.3 million) as a result of cost optimisation efforts. • EBITDA was EUR 0.9 million (2023: EUR -6.5 million). • Net loss was EUR -1.6 million (2023: EUR -9.7 million). Although the income was supported by higher volatility in financial markets, Group’s cost optimisation effort was partly muted due to voluntary suspension of new client registrations in the Cyprus based operating...

Continue reading

Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older

First chikungunya vaccine approved in Europe for persons as young as 12 years old. On track for launch in key European markets in the first half of 2025.COPENHAGEN, Denmark, February 28, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the European Commission has granted marketing authorization in Europe for VIMKUNYA® for active immunization for the prevention of disease caused by chikungunya virus in individuals 12 years and older. The virus-like particle (VLP) single-dose vaccine is the first chikungunya vaccine approved in Europe for persons as young as 12 years old. The approval, valid in all EU member states, as well as in Iceland, Liechtenstein, and Norway, marks the second approval of VIMKUNYA, following the approval by the U.S. Food and Drug Administration (FDA) earlier this month. Bavarian Nordic also recently submitted...

Continue reading

Lánasjóður sveitarfélaga – Ársreikningur 2024

Hagnaður ársins 2.070 milljónir króna Hagnaður Lánasjóðs sveitarfélaga nam 2.070 milljónum króna á árinu 2024 samanborið við 1.866 milljónir króna á árinu 2023. Hreinar vaxtatekjur í ár lækka um 4% á milli ára, sem rekja má til lægri verðbólgu. Heildareignir sjóðsins í lok ársins voru 211 milljarðar króna en voru 200 milljarðar í árslok 2023 sem er aukning um 5%. Heildarútlán sjóðsins námu 200 milljörðum króna í lok ársins samanborið við 191 milljarða í árslok 2023. Markaðsverðmæti verðbréfaútgáfu nam 13,9 milljörðum króna samanborið við 18,8 milljarð króna á árinu 2023. Eigið fé nam 24,8 milljörðum króna en var 22,7 milljarðar í árslok 2023. Vegið eiginfjárhlutfall samkvæmt lögum um fjármálafyrirtæki er 361% með fullri mildun. Í árslok 2023 var hlutfallið 416%. Lánasjóðurinn nýtir sér mildunarákvæði við eiginfjárútreikninga vegna útlána...

Continue reading

Orion Corporation: Managers’ transactions – Outi Vaarala

ORION CORPORATION MANAGERS’ TRANSACTIONS 28 FEBRUARY 2025 at 17.45 EET         Orion Corporation: Managers’ transactions – Outi Vaarala Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. Orion Oyj – Managers’ Transactions____________________________________________Person subject to the notification requirementName: Outi VaaralaPosition: Other senior managerIssuer: Orion OyjLEI: 74370029VAHCXDR7B745Notification type: INITIAL NOTIFICATIONReference number: 98180/7/4 ____________________________________________Transaction date: 2025-02-26Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009014377Nature of transaction: DISPOSAL Transaction...

Continue reading

SRx Health Solutions Granted Final Order to Proceed with the Acquisition by Better Choice Company

TAMPA, Fla., Feb. 28, 2025 (GLOBE NEWSWIRE) — Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, announced today that SRx Health Solutions, Inc. (“SRx”) was granted the final Order pursuant to the Business Corporations Act by the Ontario Superior Court of Justice to proceed with the acquisition by Better Choice Company. Better Choice will host its Special Meeting at 9:00 a.m., Eastern Time, on March 21, 2025, exclusively via live webcast at the following address: https://east.virtualshareholdermeeting.com/vsm/web?pvskey=BTTR2025SM. The record date for the stockholders to vote at the Special Meeting remains the close of business on January 21, 2025 (the “Record Date”).   Stockholders as of the Record Date can vote, even if they have subsequently sold their shares....

Continue reading

Audited results of INVL Baltic Farmland group of 2024

The audited consolidated net profit of INVL Baltic Farmland, AB amounted to EUR 1,836 thousand, the revenue was EUR 835 thousand for the period of 2024 (for 2023 – consolidated net profit was EUR 2,643 thousand, revenue was EUR 794 thousand). The initial forecast of INVL Baltic Farmland for year 2024 was income of EUR 835 thousand and net profit of EUR 420 thousand. INVL Baltic Farmland had revenue of EUR 835 thousand in 2024 and earned audited net profit of EUR 1,836 thousand for the year. Profit was forecasted under the assumption that the value of agricultural land holdings in the balance sheet would not change and the change in the value of trade receivables by the buyers was not assessed, but a valuation conducted by the company Matininkai showed that land holding value had increased by 9.5% to EUR 22.736 million compared to previous...

Continue reading

Landsbankinn hf.: Landsbankinn finalises acquisition of TM

Settlement and handover related to the purchase by Landsbankinn of TM tryggingar hf. from Kvika Bank took place today and Landsbankinn has assumed operation of the company. TM will be operated as a subsidiary of Landsbankinn. Lilja Björk Einarsdóttir, CEO of Landsbankinn: “TM is a robust insurance company with great employees who possess extensive knowledge of the insurance market. We look forward to working with TM’s staff to develop exciting innovations. Together, Landsbankinn and TM have a powerful service and sales network, both through experienced employees, digital solutions and branches across the country. We envision strong customer access to the products and services of both companies, creating many growth opportunities for both the Bank and TM. We also believe that the Bank’s acquisition of TM will have a positive impact on the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.